Myelodysplastic Syndromes
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndromes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant [Phase 2]
Phase 2 trial update on non-myeloablative conditioning for unrelated donor umbilical cord blood transplant completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-02Clinical Trial Update: A Trial of Lenalidomide & Azacitidine in Low Risk Myelodysplastic Syndromes [Phase 2]
Phase 2 trial of lenalidomide plus azacitidine in low-risk myelodysplastic syndromes (MDS) was terminated.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia [Phase 1, Phase 2]
A clinical trial evaluating cellular immunotherapy for high-risk myelodysplastic syndromes and acute myeloid leukemia in Phase 1/Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-10-06Clinical Trial Update: Exjade-Early-Trial [Phase 2]
Phase 2 clinical trial update for Exjade in myelodysplastic syndromes; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-23Clinical Trial Update: An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML) [Phase 2]
Phase 2 trial evaluating pevonedistat plus azacitidine versus azacitidine alone in higher-risk myelodysplastic syndromes, chronic myelomonoc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases [Phase 2]
Phase 2 trial evaluating myeloablative umbilical cord blood transplantation in various hematological diseases has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant [NA]
Clinical trial update on donor lymphocyte infusion for patients with recurrent or persistent hematologic cancer after donor stem cell transp…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD [Phase 2]
Phase 2 trial evaluating selective depletion of CD45RA+ T cells from allogeneic peripheral blood stem cell grafts to prevent GVHD; study ter…
-
CLINICAL_TRIALS trial_result · 2020-08-12Clinical Trial Update: IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT [Phase 1, Phase 2]
Clinical trial update on an IL-15 super agonist ALT-803 for relapse of hematologic malignancies after allogeneic stem cell transplant, compl…
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: Early Discharge and Outpatients Care in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Previously Treated With Intensive Chemotherapy [Phase 2]
Phase 2 clinical trial assessing early discharge and outpatient care for patients with myelodysplastic syndromes or acute myeloid leukemia p…
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder [Phase 2]
Phase 2 trial evaluating arsenic trioxide, ascorbic acid, dexamethasone, and thalidomide in chronic myeloproliferative disorders, leukemia, …
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial [Phase 3]
Phase 3 clinical trial update focusing on personalized or basic information to aid decision-making for participating in a trial.
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes [Phase 2]
This report presents Phase 2 safety and efficacy results for CC-486 in patients with Myelodysplastic Syndromes. The study is completed and r…
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine [Phase 3]
Phase 3 trial updating the efficacy and safety of intravenous rigosertib in myelodysplastic syndrome patients with excess blasts who progres…
-
CLINICAL_TRIALS trial_result · 2020-06-30Clinical Trial Update: Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts [Phase 3]
Phase 3 randomized study of ON 01910.Na in refractory myelodysplastic syndromes with excess blasts completed.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML). [Phase 1, Phase 2]
Phase Ib/IIb open-label study evaluating oral panobinostat with 5-azacitidine in adults with myelodysplastic syndromes, chronic myelomonocyt…
-
CLINICAL_TRIALS trial_result · 2020-06-02Clinical Trial Update: AZD1775 in Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis [Phase 2]
Phase 2 trial of AZD1775 in advanced acute myeloid leukemia, myelodysplastic syndromes, and myelofibrosis was terminated with posted results…
-
CLINICAL_TRIALS trial_result · 2020-05-28Clinical Trial Update: Azacitidine, Lenalidomide and DLI as Salvage Therapy for MDS, CMML and sAML Relapsing After Allo-HSCT [Phase 2]
Phase 2 clinical trial evaluating azacitidine, lenalidomide, and donor lymphocyte infusion as salvage therapy for relapsed diseases after al…
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes [Phase 3]
Phase 3 trial update for luspatercept (ACE-536) in anemia due to very low, low, or intermediate risk myelodysplastic syndromes has completed…
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy [Phase 2]
Phase 2 trial update on allogeneic bone marrow transplantation with less intensive therapy; the study was terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previously Untreated Adults With Higher-Risk Myelodysplastic Syndromes (MDS) or in Elderly Patients With Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 trial evaluating azacitidine plus durvalumab in untreated higher-risk myelodysplastic syndromes or elderly AML patients, with comple…
-
CLINICAL_TRIALS trial_result · 2020-05-04Clinical Trial Update: Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies [Phase 2]
Phase 2 trial update evaluating treosulfan-based conditioning in pediatric patients with hematological malignancies.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS) [Phase 4]
Phase 4 trial update of epoetin beta in anemic participants with myelodysplastic syndromes completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Treatment for Chronic Pain in Patients With Advanced Cancer [Phase 3]
Phase 3 clinical trial update for a treatment addressing chronic pain in patients with advanced cancer; status indicates completed.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Prophylactic DLI for the Prevention of Relapse Post HSCT in Patients With High Risk Myeloid Malignancy [Phase 2]
Phase 2 clinical trial evaluating prophylactic donor lymphocyte infusion to prevent relapse after allogeneic stem cell transplant in high-ri…